1. Cranial Suture Regeneration Mitigates Skull and Neurocognitive Defects in Craniosynostosis.
- Author
-
Yu M, Ma L, Yuan Y, Ye X, Montagne A, He J, Ho TV, Wu Y, Zhao Z, Sta Maria N, Jacobs R, Urata M, Wang H, Zlokovic BV, Chen JF, and Chai Y
- Subjects
- Animals, Behavior, Animal drug effects, Cognition drug effects, Craniosynostoses genetics, Dura Mater pathology, Dura Mater physiopathology, Gelatin pharmacology, Gene Expression Profiling, Hand Strength, Intracranial Pressure drug effects, Intracranial Pressure physiology, Locomotion drug effects, Mesenchymal Stem Cells drug effects, Methacrylates pharmacology, Mice, Inbred C57BL, Motor Activity drug effects, Organ Size drug effects, Regeneration drug effects, Skull pathology, Twist-Related Protein 1 metabolism, Wnt Signaling Pathway drug effects, Mice, Cognition physiology, Cranial Sutures physiopathology, Craniosynostoses physiopathology, Regeneration physiology, Skull physiopathology
- Abstract
Craniosynostosis results from premature fusion of the cranial suture(s), which contain mesenchymal stem cells (MSCs) that are crucial for calvarial expansion in coordination with brain growth. Infants with craniosynostosis have skull dysmorphology, increased intracranial pressure, and complications such as neurocognitive impairment that compromise quality of life. Animal models recapitulating these phenotypes are lacking, hampering development of urgently needed innovative therapies. Here, we show that Twist1
+/- mice with craniosynostosis have increased intracranial pressure and neurocognitive behavioral abnormalities, recapitulating features of human Saethre-Chotzen syndrome. Using a biodegradable material combined with MSCs, we successfully regenerated a functional cranial suture that corrects skull deformity, normalizes intracranial pressure, and rescues neurocognitive behavior deficits. The regenerated suture creates a niche into which endogenous MSCs migrated, sustaining calvarial bone homeostasis and repair. MSC-based cranial suture regeneration offers a paradigm shift in treatment to reverse skull and neurocognitive abnormalities in this devastating disease., Competing Interests: Declaration of Interests The authors declare no competing interests., (Copyright © 2020 Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF